Condition: Ischemic Stroke, Acute · Sponsor: Beijing Tiantan Hospital
Shuxuening injection is a multi-target neuroprotective agent, it is expected to play a neuroprotective role on the basis of intravenous thrombolysis therapy. The primary purpose of this multicenter, randomized, double-blind, placebo-parallel controlled trial is to evaluate the efficacy and safety of Shuxuening injection in the treatment with intravenous thrombolysis in patients with ischemic stroke.
This description comes directly from the study's public registry record.
Anxin Wang · +86 1059975806 · anxin0907@163.com
Always discuss trial participation with your own doctor first.
| Fangshan District First Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Chongqing Nanchuan District People's Hospital | Chongqing, Chongqing Municipality, China | Recruiting |
| Chongqing Sanbo Chang'an Hospital | Chongqing, Chongqing Municipality, China | Recruiting |
| Chongqing Qianjiang Central Hospital | Qianjiang, Chongqing Municipality, China | Recruiting |
| The First Affiliated Hospital of Guangdong Pharmaceutical University | Guangzhou, Guangdong, China | Recruiting |
| Heyuan People's Hospital | Heyuan, Guangdong, China | Recruiting |
| Huazhou People's Hospital | Maoming, Guangdong, China | Recruiting |
| Meizhou Hospital of Traditional Chinese Medicine | Meizhou, Guangdong, China | Recruiting |
| Yunfu People's Hospital | Yunfu, Guangdong, China | Recruiting |
| Wuchuan People's Hospital | Zhanjiang, Guangdong, China | Recruiting |
| Zhongshan People's Hospital | Zhongshan, Guangdong, China | Recruiting |
| The Fifth Affiliated Hospital of Sun Yat-sen University | Zhuhai, Guangdong, China | Recruiting |
+ 70 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06157502